Correlation Between Galera Therapeutics and Intellipharmaceutics
Can any of the company-specific risk be diversified away by investing in both Galera Therapeutics and Intellipharmaceutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Galera Therapeutics and Intellipharmaceutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Galera Therapeutics and Intellipharmaceutics International, you can compare the effects of market volatilities on Galera Therapeutics and Intellipharmaceutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Galera Therapeutics with a short position of Intellipharmaceutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Galera Therapeutics and Intellipharmaceutics.
Diversification Opportunities for Galera Therapeutics and Intellipharmaceutics
-0.16 | Correlation Coefficient |
Good diversification
The 3 months correlation between Galera and Intellipharmaceutics is -0.16. Overlapping area represents the amount of risk that can be diversified away by holding Galera Therapeutics and Intellipharmaceutics Internati in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Intellipharmaceutics and Galera Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Galera Therapeutics are associated (or correlated) with Intellipharmaceutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Intellipharmaceutics has no effect on the direction of Galera Therapeutics i.e., Galera Therapeutics and Intellipharmaceutics go up and down completely randomly.
Pair Corralation between Galera Therapeutics and Intellipharmaceutics
Given the investment horizon of 90 days Galera Therapeutics is expected to generate 13.35 times less return on investment than Intellipharmaceutics. But when comparing it to its historical volatility, Galera Therapeutics is 10.19 times less risky than Intellipharmaceutics. It trades about 0.08 of its potential returns per unit of risk. Intellipharmaceutics International is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest 7.00 in Intellipharmaceutics International on September 5, 2024 and sell it today you would lose (3.20) from holding Intellipharmaceutics International or give up 45.71% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Galera Therapeutics vs. Intellipharmaceutics Internati
Performance |
| Timeline |
| Galera Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Intellipharmaceutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Galera Therapeutics and Intellipharmaceutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Galera Therapeutics and Intellipharmaceutics
The main advantage of trading using opposite Galera Therapeutics and Intellipharmaceutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Galera Therapeutics position performs unexpectedly, Intellipharmaceutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Intellipharmaceutics will offset losses from the drop in Intellipharmaceutics' long position.| Galera Therapeutics vs. Mereo BioPharma Group | Galera Therapeutics vs. Terns Pharmaceuticals | Galera Therapeutics vs. PDS Biotechnology Corp | Galera Therapeutics vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Complementary Tools
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |